FORM 8-K

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 19, 2004

 

QuadraMed Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   0-21031   52-1992861
(State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)

 

12110 Sunset Hills Road, Suite 600, Reston, VA 20190

(Address of principal executive office and zip code)

 

(703) 709-2300

(Registrant’s telephone number, including area code)

 

(Not Applicable)

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



TABLE OF CONTENTS

 

ITEM 8.01 OTHER EVENTS.

 

SIGNATURES



Item 8.01 Other Events.

 

On November 22, 2004, QuadraMed Corporation announced that Lawrence P. English, Chairman and Chief Executive Officer, held an all-company conference call with employees on Friday, November 19, 2004. During the call, Mr. English provided an update on the Company’s progress. The audio of the conference call is available on the Company’s website at www.quadramed.com under Investor Relations in the Presentations and Conference Calls section.

 

v

 

The information in this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 22, 2004

 

 

QuadraMed Corporation

/s/ Lawrence P. English

Lawrence P. English

Chairman and Chief Executive Officer